About: http://data.cimple.eu/news-article/7ab7cadb1cde5d322136476cb2a1e4c8c92e23eff18b94986dc86a1f

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/7ab7cadb1cde5d322136476cb2a1e4c8c92e23eff18b94986dc86a1f Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Thailand is conducting tests on macaque monkeys as it races to produce a cheaper, alternative coronavirus vaccine it hopes will be ready by 2021, a top researcher said Monday. More than 100 candidate vaccines are currently in various stages of development around the world, at least eight of which are in clinical trials with humans, according to the World Health Organization. Oxford University researchers are considered the frontrunners in the race, starting clinical trials last month on a version based on a different virus that causes infections in chimpanzees. Dr. Suchinda Malaivitjitnond, director of the National Primate Research Center of Thailand who oversaw Saturday's vaccine injections to an initial group of 13 monkeys, said she hoped a "Made in Thailand" vaccine would be cheaper than a European or American drug. The testing phase on the macaque monkeys came after trials on mice were successful, researchers said. They are working in collaboration with the University of Pennsylvania in the US using a new technology based on mRNA, a type of genetic material never before used to make a vaccine. The process entails injecting a short sequence of viral genetic material to trigger an immune response by producing proteins acting against the virus. At least two other companies -- pharmaceutical giant Pfizer and US-based Moderna -- are developing vaccines using the same technology, with the latter reporting positive preliminary results last week from clinical trials. Thailand was the first country outside of China to detect an infection in mid-January but has so far reported just over 3,000 cases and 57 deaths. If the tests on the macaques go well, human trials should start in October, said Dr. Kiat Ruxrungtham, chair of the Chula Vaccine Research Center at Chulalongkorn University. "Our dream is that low- and middle-income countries should not stay a buyer for our whole lives." dhc/rs/rma
schema:headline	Thailand enters global race for vaccine with trials on monkeys
schema:mentions	Primate USA Gymnastics Pharmaceutical industry University of Oxford World Health Organization Thailand Messenger RNA Virus Pfizer Vaccine United States China Severe acute respiratory syndrome coronavirus 2 Vaccine Research Center Chulalongkorn University University of Pennsylvania Immunogenicity Memphis Bleek Qiang language
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-05-25 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	86 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 6 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software